North America region held the highest share in 2023.
Antisense and RNAi Therapeutics Market was valued at US$ 1.63 Bn. in 2023 and is expected to reach US$ 3.38 Bn. by 2030, at a CAGR of 11% during the forecast period of 2024 to 2030.
Antisense & RNAi Therapeutics Market Overview:
The latest study from Maximize Market Research, Global Antisense & RNAi Therapeutics Market, is...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Português
Ελληνικά
Tiếng Việt